Atlas Trials

Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction

Clinical trial NCT06652087 · RECRUITING

Trial details

NCT number
NCT06652087
Sponsor
I.M. Sechenov First Moscow State Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Bacterial Overgrowth Syndrome Small BowelHeart Failure with Preserved Ejection Fraction
Start date
2024-09-02
Primary completion
2026-09-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.